Daryl Freeman

发表

Earlier diagnosis and earlier treatment of COPD in primary care.

David Price, Jen Cleland, Alan Kaplan, 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study

D. Price, D. Freeman, Angela Lee, 2007, Respiratory research.

The Importance of Self-Management in the Context of Personalized Care in COPD

D. Freeman, S. Holmes, Sally J Singh, 2022, International journal of chronic obstructive pulmonary disease.

British Thoracic Society guidelines for home oxygen use in adults: accredited by NICE

W. MacNee, A. Evans, M. Hardinge, 2015, Thorax.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

D. Price, E. Bateman, D. Ryan, 2014, The Lancet. Respiratory medicine.

Symptom-Based Questionnaire for Identifying COPD in Smokers

D. Price, E. Juniper, R. Nordyke, 2006, Respiration.

Questions for COPD diagnostic screening in a primary care setting.

D. Price, R. Nordyke, R. Halbert, 2005, Respiratory medicine.

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.

D. Price, K. Ohta, D. Ryan, 2018, The Lancet. Respiratory medicine.

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care

D. Price, D. Ryan, Mike Thomas, 2013, Clinical and Translational Allergy.

Blood eosinophil count and exacerbation risk in patients with COPD

Todor A Popov, D. Postma, I. Pavord, 2017, European Respiratory Journal.

ABS74: Large variations in asthma control between UK general practices participating in the asthma control, concordance and tolerance (ACCT) Initiative

D. Price, R. Horne, D. Ryan, 2006 .

Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

D. Price, Andrew M. Wilson, D. Sexton, 2014, International journal of chronic obstructive pulmonary disease.

Symptom-Based Questionnaire for Differentiating COPD and Asthma

D. Price, E. Juniper, R. Nordyke, 2006, Respiration.

Real-world research and its importance in respiratory medicine

N. Roche, G. Brusselle, A. Chisholm, 2015, Breathe.

Predicting frequent COPD exacerbations using primary care data

D. Price, M. Kerkhof, A. Chisholm, 2015, International journal of chronic obstructive pulmonary disease.

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

D. Price, E. Juniper, L. Shepstone, 2011, The New England journal of medicine.

When should I be considering home oxygen for my patients?

M. Hardinge, D. Freeman, I. Patel, 2016, npj Primary Care Respiratory Medicine.

Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practice

N. Snowise, D. Freeman, A. De Soyza, 2022, BMJ Open Respiratory Research.

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide

D. Price, Mike Thomas, A. Kaplan, 2015, Journal of asthma and allergy.

Blood eosinophil count and exacerbation risk in patients with COPD

Todor A Popov, D. Postma, I. Pavord, 2017, European Respiratory Journal.

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).

D. Price, M. Mugford, E. Juniper, 2011, Health technology assessment.

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

New Approaches for Managing Influenza in Primary Care

D. Fleming, C. Silagy, D. Freeman, 2001 .

British Thoracic Society guidelines for home oxygen use in adults: accredited by NICE

A. Evans, M. Hardinge, T. Wilkinson, 2015, Thorax.

Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.

L. Shepstone, J. Murdoch, J. Ayres, 2010, PharmacoEconomics.

Blood eosinophilia and the number of exacerbations in COPD patients

D. Postma, I. Pavord, D. Price, 2014 .

Detecting mild COPD is not a waste of resources.

D. Price, J. Cleland, A. Kaplan, 2011, Primary care respiratory journal : journal of the General Practice Airways Group.

Long-acting β2-agonists in COPD

D. Freeman, Daryl Freeman, 2001 .